Searchable abstracts of presentations at key conferences in endocrinology

ea0035p487 | Diabetes therapy | ECE2014

Changes in insulin sensitivity and DHEAS in type 2 diabetic men treated with liraglutide

Piedrola Gonzalo , Cepero Daniel , Gil Concepcion , Ramirez Jessica , Roa Ricardo

DHEAS, an adrenal steroid which displays antiatherogenic and cardioprotective actions, has been pointed as a marker of insulin sensivity (IS). No studies have inquired the effects of liraglutide on DHEAS levels and its relatioship with IS in patients with type 2 diabetes.Methods: We have studied 12 diabetic male patients (aged 48.6±10.4 years), before and after 6 months of liraglutide therapy. Liraglutide was initiated at 0.6 mg/day for a week and 1...

ea0022p425 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Clinical features and outcome of sporadic medullary thyroid carcinoma

Sanchez Sobrino Paula , Paramo Fernandez Concepcion , Gil Beatriz Mantinan , Perez Pedrosa Alberto , Palmeiro Carballeiro Regina , Seoane Cruz Ines , Garcia-Mayor Ricardo V

Introduction: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumour that arises from c cells of the thyroid gland and accounts for less than 8% of thyroid neoplasms. Some are familiar (MEN 2 syndrome) but most are sporadic. Genetic tests have improved the outcome in hereditary forms, but survival in sporadic MTC has not increased in last years. In most patients with sporadic MTC the disease has already metastasized at the time of diagnosis.Objecti...